Answer
Elocta (efmoroctocog alfa) should be used during pregnancy and breastfeeding only if clearly indicated, because experience with factor VIII use in these circumstances is unavailable owing to the rarity of haemophilia A in women.
Sources for this answer
- ELOCTA 250 IU powder and solvent for solution for injectionSwedish Orphan Biovitrum Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 11Document updated
Sources checked